Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update

NEXT STORY
Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO
PREV STORY
Airway Management Devices Global Market Report 2020-30: Covid 19 Implications and Growth
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

iTeos to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 12, 2021

author_avatar
NASDAQ Market News

Immunomedics Announces Termination of Epratuzumab Licensing Agreement With UCB

MORRIS PLAINS, N.J., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced ...

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2018 Financial Results and Business Update

author_avatar
NASDAQ Market News